Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generation of Biological Samples Positive to Hydromorphone for Anti-doping Control
NCT04081376Phase 1Completed
- Sponsor
- Parc de Salut Mar
- Start
- Nov 2019
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of hydromorphone in pain, sponsored by Parc de Salut Mar. Primary endpoint: Urine concentration of hydromorphone. Started Nov 2019; status: completed.
02
Drugs
hydromorphone
03
Conditions
pain
Beyond the preview
Go deeper on NCT04081376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04081376.